Lv3
240 积分 2021-04-15 加入
The key roles of the lysine acetyltransferases KAT6A and KAT6B in physiology and pathology
7天前
已完结
Targeting KAT6A/B as a New Therapeutic Strategy for Cancer Therapy
7天前
已完结
Drug Delivery Strategy Exploiting Amino Acid Prodrugs: Improving Oral Bioavailability and Overcoming Nonlinear Pharmacokinetic Challenges Following Dose Escalation of a CK2 Inhibitor with Poor Solubility
8天前
已完结
Discovery of Potential First-in-Class Dual Ligand-Directed Degrader and Antagonist of the Androgen Receptor: BMS-986365
8天前
已完结
A conformation-locking inhibitor of SLC15A4 with TASL proteostatic anti-inflammatory activity
15天前
已完结
Discovery of SYD5115, a novel orally active small molecule TSH-R antagonist
16天前
已完结
Safety considerations for cereblon-recruiting targeted protein degraders
24天前
已完结
Identification of Novel Series of Potent and Selective Relaxin Family Peptide Receptor 1 (RXFP1) Agonists
24天前
已完结
Discovery of Clinical Candidate AZD5462, a Selective Oral Allosteric RXFP1 Agonist for Treatment of Heart Failure
24天前
已完结
Small Molecule Allosteric Inhibitor of HIPK2 as a Novel Therapy against Kidney Fibrosis
26天前
已完结
皖公网安备34019202002308
